Publication:
Using coding and non-coding rare variants to target candidate genes in patients with severe tinnitus

dc.contributor.authorGallego-Martinez, Alvaro
dc.contributor.authorEscalera-Balsera, Alba
dc.contributor.authorTrpchevska, Natalia
dc.contributor.authorRobles-Bolivar, Paula
dc.contributor.authorRoman-Naranjo, Pablo
dc.contributor.authorFrejo, Lidia
dc.contributor.authorPerez-Carpena, Patricia
dc.contributor.authorBulla, Jan
dc.contributor.authorGallus, Silvano
dc.contributor.authorCanlon, Barbara
dc.contributor.authorCederroth, Christopher R. R.
dc.contributor.authorLopez-Escamez, Jose A. A.
dc.contributor.authoraffiliation[Gallego-Martinez, Alvaro] Univ Granada, Ctr Genom & Oncol Res Pfizer, Dept Genom Med, Otol & Neurotol Grp CTS495,GENYO,Andalusian Reg Go, Ave Ilustrac 114, Granada 18016, Spain
dc.contributor.authoraffiliation[Escalera-Balsera, Alba] Univ Granada, Ctr Genom & Oncol Res Pfizer, Dept Genom Med, Otol & Neurotol Grp CTS495,GENYO,Andalusian Reg Go, Ave Ilustrac 114, Granada 18016, Spain
dc.contributor.authoraffiliation[Robles-Bolivar, Paula] Univ Granada, Ctr Genom & Oncol Res Pfizer, Dept Genom Med, Otol & Neurotol Grp CTS495,GENYO,Andalusian Reg Go, Ave Ilustrac 114, Granada 18016, Spain
dc.contributor.authoraffiliation[Roman-Naranjo, Pablo] Univ Granada, Ctr Genom & Oncol Res Pfizer, Dept Genom Med, Otol & Neurotol Grp CTS495,GENYO,Andalusian Reg Go, Ave Ilustrac 114, Granada 18016, Spain
dc.contributor.authoraffiliation[Frejo, Lidia] Univ Granada, Ctr Genom & Oncol Res Pfizer, Dept Genom Med, Otol & Neurotol Grp CTS495,GENYO,Andalusian Reg Go, Ave Ilustrac 114, Granada 18016, Spain
dc.contributor.authoraffiliation[Perez-Carpena, Patricia] Univ Granada, Ctr Genom & Oncol Res Pfizer, Dept Genom Med, Otol & Neurotol Grp CTS495,GENYO,Andalusian Reg Go, Ave Ilustrac 114, Granada 18016, Spain
dc.contributor.authoraffiliation[Lopez-Escamez, Jose A. A.] Univ Granada, Ctr Genom & Oncol Res Pfizer, Dept Genom Med, Otol & Neurotol Grp CTS495,GENYO,Andalusian Reg Go, Ave Ilustrac 114, Granada 18016, Spain
dc.contributor.authoraffiliation[Gallego-Martinez, Alvaro] Hosp Univ Virgen de las Nieves, Inst Invest Biosanit, Ibs Granada, Dept Otolaryngol, Granada 18014, Spain
dc.contributor.authoraffiliation[Escalera-Balsera, Alba] Hosp Univ Virgen de las Nieves, Inst Invest Biosanit, Ibs Granada, Dept Otolaryngol, Granada 18014, Spain
dc.contributor.authoraffiliation[Robles-Bolivar, Paula] Hosp Univ Virgen de las Nieves, Inst Invest Biosanit, Ibs Granada, Dept Otolaryngol, Granada 18014, Spain
dc.contributor.authoraffiliation[Roman-Naranjo, Pablo] Hosp Univ Virgen de las Nieves, Inst Invest Biosanit, Ibs Granada, Dept Otolaryngol, Granada 18014, Spain
dc.contributor.authoraffiliation[Frejo, Lidia] Hosp Univ Virgen de las Nieves, Inst Invest Biosanit, Ibs Granada, Dept Otolaryngol, Granada 18014, Spain
dc.contributor.authoraffiliation[Perez-Carpena, Patricia] Hosp Univ Virgen de las Nieves, Inst Invest Biosanit, Ibs Granada, Dept Otolaryngol, Granada 18014, Spain
dc.contributor.authoraffiliation[Lopez-Escamez, Jose A. A.] Hosp Univ Virgen de las Nieves, Inst Invest Biosanit, Ibs Granada, Dept Otolaryngol, Granada 18014, Spain
dc.contributor.authoraffiliation[Gallego-Martinez, Alvaro] CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Sensorineural Pathol Programme, Madrid 28029, Spain
dc.contributor.authoraffiliation[Escalera-Balsera, Alba] CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Sensorineural Pathol Programme, Madrid 28029, Spain
dc.contributor.authoraffiliation[Robles-Bolivar, Paula] CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Sensorineural Pathol Programme, Madrid 28029, Spain
dc.contributor.authoraffiliation[Roman-Naranjo, Pablo] CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Sensorineural Pathol Programme, Madrid 28029, Spain
dc.contributor.authoraffiliation[Frejo, Lidia] CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Sensorineural Pathol Programme, Madrid 28029, Spain
dc.contributor.authoraffiliation[Perez-Carpena, Patricia] CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Sensorineural Pathol Programme, Madrid 28029, Spain
dc.contributor.authoraffiliation[Lopez-Escamez, Jose A. A.] CIBERER, Ctr Invest Biomed Red Enfermedades Raras, Sensorineural Pathol Programme, Madrid 28029, Spain
dc.contributor.authoraffiliation[Trpchevska, Natalia] Karolinska Inst, Dept Physiol & Pharmacol, Sect Expt Audiol, S-17177 Stockholm, Sweden
dc.contributor.authoraffiliation[Canlon, Barbara] Karolinska Inst, Dept Physiol & Pharmacol, Sect Expt Audiol, S-17177 Stockholm, Sweden
dc.contributor.authoraffiliation[Cederroth, Christopher R. R.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Expt Audiol, S-17177 Stockholm, Sweden
dc.contributor.authoraffiliation[Perez-Carpena, Patricia] Univ Granada, Dept Surg, Div Otolaryngol, Granada 18016, Spain
dc.contributor.authoraffiliation[Lopez-Escamez, Jose A. A.] Univ Granada, Dept Surg, Div Otolaryngol, Granada 18016, Spain
dc.contributor.authoraffiliation[Bulla, Jan] Univ Bergen, Dept Math, N-5020 Bergen, Norway
dc.contributor.authoraffiliation[Bulla, Jan] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany
dc.contributor.authoraffiliation[Gallus, Silvano] Ist Ric Farmacol Mario Negri IRCCS, Dept Environm Hlth Sci, I-20156 Milan, Italy
dc.contributor.authoraffiliation[Cederroth, Christopher R. R.] Nottingham Univ Hosp NHS Trust, Natl Inst Hlth Res NIHR, Nottingham Biomed Res Ctr, Ropewalk House, Nottingham NG1 5DU, England
dc.contributor.authoraffiliation[Cederroth, Christopher R. R.] Univ Nottingham, Sch Med, Div Clin Neurosci, Hearing Sci, Nottingham NG7 2UH, England
dc.contributor.funder"La Caixa" Foundation
dc.contributor.funderEuropean Union
dc.contributor.funderSvenska Lakaresalskapet
dc.contributor.funderHoerselforskningsfonden
dc.contributor.funderTysta Skolan and Forschung Fuer Leben
dc.contributor.funderAndalusian Health Government
dc.contributor.funderSwedish Research Council
dc.date.accessioned2023-05-03T13:26:27Z
dc.date.available2023-05-03T13:26:27Z
dc.date.issued2022-11-18
dc.description.abstractTinnitus is the phantom percept of an internal non-verbal set of noises and tones. It is reported by 15% of the population and it is usually associated with hearing and/or brain disorders. The role of structural variants (SVs) in coding and non-coding regions has not been investigated in patients with severe tinnitus. In this study, we performed whole-genome sequencing in 97 unrelated Swedish individuals with chronic tinnitus (TIGER cohort). Rare single nucleotide variants (SNV), large structural variants (LSV), and copy number variations (CNV) were retrieved to perform a gene enrichment analysis in TIGER and in a subgroup of patients with severe tinnitus (SEVTIN, n = 34), according to the tinnitus handicap inventory (THI) scores. An independent exome sequencing dataset of 147 Swedish tinnitus patients was used as a replication cohort (JAGUAR cohort) and population-specific datasets from Sweden (SweGen) and Non-Finish Europeans (NFE) from gnomAD were used as control groups. SEVTIN patients showed a higher prevalence of hyperacusis, hearing loss, and anxiety when they were compared to individuals in the TIGER cohort. We found an enrichment of rare missense variants in 6 and 8 high-constraint genes in SEVTIN and TIGER cohorts, respectively. Of note, an enrichment of missense variants was found in the CACNA1E gene in both SEVTIN and TIGER. We replicated the burden of missense variants in 9 high-constrained genes in the JAGUAR cohort, including the gene NAV2, when data were compared with NFE. Moreover, LSVs in constrained regions overlapping CACNA1E, NAV2, and TMEM132D genes were observed in TIGER and SEVTIN.
dc.description.sponsorshipThis study was partially funded by GNP-182 GENDER-Net Co-Plus Fund including support from “La Caixa” Foundation (ID 100010434), under agreement LCF/PR/DE18/52010002 and H2020-SC1-2019-848261 (JALE and CRC). JALE and CRC also received additional support from the European Union’s Horizon 2020 Research and Innovation Programme, Grant Agreement No 848261 and the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 722046. CRC received additional funding from Svenska Läkaresällskapet (SLS-779681), Hörselforskningsfonden (503), Tysta Skolan and Forschung Für Leben. JALE has received funds from Andalusian Goverment (CECEU 2020, grant code: DOC_01677). LF has received funds from Sara Borrell postdoctoral Fellowship (ISCIII; grant code: CD20/00153). PPC has received funds from the Andalusian Health Government (CSyF 2020 POSTDOC, Grant code: RH-0150-2020). The computations and data handling were enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) at SNIC/UPPMAX partially funded by the Swedish Research Council through grant agreement no. 2018- 05973. We are indebted to Nancy Pedersen for sharing DNA material from LifeGene.
dc.description.versionSi
dc.identifier.citationGallego-Martinez A, Escalera-Balsera A, Trpchevska N, Robles-Bolivar P, Roman-Naranjo P, Frejo L, et al. Using coding and non-coding rare variants to target candidate genes in patients with severe tinnitus. NPJ Genom Med. 2022 Nov 30;7(1):70.
dc.identifier.doi10.1038/s41525-022-00341-w
dc.identifier.essn2056-7944
dc.identifier.unpaywallURLhttps://www.nature.com/articles/s41525-022-00341-w.pdf
dc.identifier.urihttp://hdl.handle.net/10668/19555
dc.identifier.wosID892976200001
dc.issue.number1
dc.journal.titleNpj genomic medicine
dc.journal.titleabbreviationNpj genom. med.
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationCentro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number9
dc.publisherNature portfolio
dc.publisherNature Publishing Group
dc.relation.projectIDID 100010434
dc.relation.projectIDLCF/PR/DE18/52010002
dc.relation.projectID848261
dc.relation.projectIDH2020-SC1-2019-848261
dc.relation.projectIDSLS-779681
dc.relation.projectIDCD20/00153
dc.relation.projectIDRH-0150-2020
dc.relation.projectID2018-05973
dc.relation.publisherversionhttps://doi.org/10.1038/s41525-022-00341-w
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectJoint consensus recommendation
dc.subjectStructural variants
dc.subjectMammalian homolog
dc.subjectMedical genetics
dc.subjectAmerican-college
dc.subjectAssociation
dc.subjectMechanisms
dc.subjectGuidelines
dc.subjectStandards
dc.subjectFramework
dc.subject.decsAcúfeno
dc.subject.decsAnsiedad
dc.subject.decsAudición
dc.subject.decsEncefalopatías
dc.subject.decsHiperacusia
dc.subject.decsNucleótidos
dc.subject.decsPrevalencia
dc.subject.decsPérdida auditiva
dc.subject.decsSecuenciación del exoma
dc.subject.decsVariaciones en el número de copia de ADN
dc.subject.decsSordera
dc.subject.meshHumans
dc.subject.meshTinnitus
dc.subject.meshSweden
dc.subject.meshDNA Copy Number Variations
dc.subject.meshExome Sequencing
dc.subject.meshHyperacusis
dc.subject.meshPrevalence
dc.subject.meshControl Groups
dc.subject.meshHearing
dc.subject.meshHearing Loss
dc.subject.meshDeafness
dc.subject.meshAnxiety
dc.subject.meshBrain Diseases
dc.subject.meshNucleotides
dc.titleUsing coding and non-coding rare variants to target candidate genes in patients with severe tinnitus
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number7
dc.wostypeArticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Gallego_Using.pdf
Size:
1.95 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Gallego_Using_MaterialSuplementario.pdf
Size:
2.55 MB
Format:
Adobe Portable Document Format